Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis

Fig. 2

Forest plots of sPD-L1 versus OS/PFS in NSCLC patients undergoing ICI therapy. a–b, sPD-L1 expression versus OS/PFS; Costantini (2018a) and Tiako Meyo (2020a) examined the pre-treatment levels of sPD-L1; Costantini (2018b) and Tiako Meyo (2020b) examined the dynamic changes in the post-treatment sPD-L1 levels

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us